Showing results (1-10 of 70) with videos related to
Sort By:
Pageof 7
Archives of Medical Research|October 27, 2009
The therapeutic vaccine: is it feasible?Lutz Gissmann, Karen NietoCollegium Antropologicum|June 30, 2007
Development of prophylactic HPV vaccinesLutz Gissmann, Martin MüllerCurrent Opinion in Biotechnology|November 25, 2004
Virus-like particles as vaccines and vessels for the delivery of small moleculesRobert L Garcea, Lutz GissmannAntiviral Therapy|August 5, 2008
Comparison of DNA- and mRNA-transfected mouse dendritic cells as potential vaccines against the human papillomavirus type 16 associated oncoprotein E7Kerstin Dell, Corinna Klein, Lutz GissmannImmunology Letters|September 5, 2006
Codon optimized expression of HPV 16 E6 renders target cells susceptible to E6-specific CTL recognitionRegina Samorski, Lutz Gissmann, Wolfram OsenInternational Journal of Cancer|July 30, 2005
Transcutaneous immunization in mice: induction of T-helper and cytotoxic T lymphocyte responses and protection against human papillomavirus-induced tumorsKerstin Dell, Robert Koesters, Lutz GissmannCurrent Opinion in Virology|August 5, 2017
Human papillomaviruses and carcinogenesis: well-established and novel modelsDaniele Viarisio, Lutz Gissmann, Massimo TommasinoAntiviral Therapy|November 3, 2010
Human papillomavirus-specific immune therapy: failure and hopeKaren Nieto, Lutz Gissmann, Lysann SchädlichVaccine|October 14, 2008
Immunobiology of human papillomavirus infection and vaccination - implications for second generation vaccinesMargaret Stanley, Lutz Gissmann, Denise Nardelli-HaefligerPageof 7